Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Excision Site”

289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 289 results

Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Not applicableWithdrawnNCT02103946
What this trial is testing

Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia

Who this might be right for
Breast CancerAcute Pain
National Cancer Institute, Egypt
Not applicableNot Yet RecruitingNCT07237828
What this trial is testing

Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR

Who this might be right for
Breast Cancer
Du Zhenggui 379
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836
What this trial is testing

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 976
Not applicableUnknownNCT06488612
What this trial is testing

Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting

Who this might be right for
Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts
Sohag University 20
Not applicableLooking for participantsNCT07532434
What this trial is testing

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Peking University Third Hospital 480
Testing effectiveness (Phase 2)Study completedNCT02126579
What this trial is testing

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

Who this might be right for
MelanomaMetastatic MelanomaMucosal Melanoma
Craig L Slingluff, Jr 50
Testing effectiveness (Phase 2)Ended earlyNCT05060003
What this trial is testing

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

Who this might be right for
Stage II Melanoma
Washington University School of Medicine 7
Large-scale testing (Phase 3)Ended earlyNCT01568346
What this trial is testing

Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 9
Not applicableNo Longer AvailableNCT04544202
What this trial is testing

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Who this might be right for
MelanomaAdjuvant
Novartis Pharmaceuticals
Early research (Phase 1)Ended earlyNCT03394937
What this trial is testing

Safety of Intranodal ECI-006 in Melanoma Patients

Who this might be right for
Melanoma
eTheRNA immunotherapies 21
Testing effectiveness (Phase 2)Study completedNCT00060333
What this trial is testing

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

Who this might be right for
Recurrent Melanoma
Alliance for Clinical Trials in Oncology 20
Not applicableLooking for participantsNCT07049276
What this trial is testing

The Multicentre Selective Lymphadenectomy Trial - 3

Who this might be right for
Cutaneous Melanoma, Stage III
Melanoma Institute Australia 1,500
Testing effectiveness (Phase 2)Study completedNCT00020358
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT06300411
What this trial is testing

SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery

Who this might be right for
Breast Cancer
SURGE Therapeutics 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04967391
What this trial is testing

Tumescence in HNC Skin Graft Reconstruction

Who this might be right for
Head and Neck CancerSurgery--ComplicationsGraft Failure
University of California, Davis 58
Not applicableStudy completedNCT00072293
What this trial is testing

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 931
Not applicableStudy completedNCT02166996
What this trial is testing

A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck

Who this might be right for
Cutaneous Tumors
Sundsvall Hospital 116
Not applicableUnknownNCT02666079
What this trial is testing

The LightPath® Breast Cancer Study

Who this might be right for
Breast Cancer
Lightpoint Medical Limited 170
Next Page